Schunkert H, Ingelfinger J R, Dzau V J
Division of Vascular Medicine, Brigham and Women's Hospital, Boston, Mass.
Ren Physiol Biochem. 1991 Jul-Oct;14(4-5):146-54. doi: 10.1159/000173400.
Previous physiological and biochemical studies suggest the existence of an endogenous renin-angiotensin system (RAS) in the kidney. However, these data cannot exclude the contribution of the circulating RAS. Proof of the local synthesis of RAS components in the kidney has been obtained recently through the use of molecular biological techniques. Using Northern blot analysis, we have demonstrated the intrarenal expression of renin, angiotensinogen, and angiotensin-converting enzyme messenger RNAs. Employing in situ hybridization histochemistry, we have localized the intrarenal tissue sites of renin and angiotensinogen messenger RNA synthesis. Renin gene expression was found in cells of the juxtaglomerular apparatus. Angiotensinogen mRNA was primarily produced in the proximal convoluted tubule with lesser amounts in glomerular tufts and vasculature. These findings led us to hypothesize that the proximal tubule is a major site of renal Ang II synthesis and that locally synthesized Ang II might directly modulate tubular function. Both genes are subject to feedback regulation. Our studies showed that Ang II exerted a stimulatory effect on angiotensinogen but a negative feedback effect on renin gene expression. Dietary NaCl restriction stimulated the expression of both genes, although the onset of renin gene activation required more prolonged sodium chloride restriction. Furthermore, our data indicated that the sodium cation, irrespective of the anion, was primarily important in regulating renal angiotensinogen mRNA levels. Our studies also showed altered intrarenal renin or angiotensinogen expressions in pathophysiological states, e.g. in experimental heart failure and the spontaneously hypertensive rat. Taken together, these data support the existence of a intrarenal RAS and suggest its potential roles in the regulation of renal function in health and disease.
以往的生理生化研究提示,肾脏中存在内源性肾素 - 血管紧张素系统(RAS)。然而,这些数据并不能排除循环RAS的作用。最近通过使用分子生物学技术,已获得肾脏中RAS组分局部合成的证据。利用Northern印迹分析,我们已证实肾素、血管紧张素原和血管紧张素转换酶信使RNA在肾内的表达。采用原位杂交组织化学方法,我们已确定肾素和血管紧张素原信使RNA合成的肾内组织部位。发现肾素基因在球旁器细胞中表达。血管紧张素原mRNA主要在近端小管产生,在肾小球丛和脉管系统中产生较少。这些发现使我们推测近端小管是肾内血管紧张素II合成的主要部位,并且局部合成的血管紧张素II可能直接调节肾小管功能。这两个基因均受到反馈调节。我们的研究表明,血管紧张素II对血管紧张素原发挥刺激作用,但对肾素基因表达发挥负反馈作用。饮食中NaCl限制刺激了这两个基因的表达,尽管肾素基因激活的开始需要更长时间的氯化钠限制。此外,我们的数据表明,无论阴离子如何,钠阳离子在调节肾血管紧张素原mRNA水平方面主要起重要作用。我们的研究还表明,在病理生理状态下,例如在实验性心力衰竭和自发性高血压大鼠中,肾内肾素或血管紧张素原表达发生改变。综上所述,这些数据支持肾内RAS的存在,并提示其在健康和疾病状态下肾功能调节中的潜在作用。